Search research articles
Contact Us
Filters
Showing results (461-470 of 633) with videos related to
Page
of 64
Sort By:
Biochemical Pharmacology
|
February 12, 2020
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor
Chao-Yun Cai, Wei Zhang, Jing-Quan Wang, et al.
Biochemical Pharmacology
|
June 14, 2021
CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)
Jing-Quan Wang, Bo Wang, Qiu-Xu Teng, et al.
Frontiers in Oncology
|
March 17, 2020
Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells
Jingqiu Wang, Jing-Quan Wang, Chao-Yun Cai, et al.
Plos One
|
October 21, 2009
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10)
Tong Shen, Ye-Hong Kuang, Charles R Ashby, et al.
Biochemical Pharmacology
|
May 13, 2019
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells
Zhuo-Xun Wu, Qiu-Xu Teng, Chao-Yun Cai, et al.
Oncology Reports
|
January 17, 2009
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
Zhi Shi, Smitaben Parmar, Xing-Xiang Peng, et al.
Pharmacological Research
|
January 30, 2017
Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib
Guan-Nan Zhang, Yun-Kai Zhang, Yi-Jun Wang, et al.
Cancer Science
|
July 21, 2007
Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells
Zhi Shi, Sandeep Jain, In-Wha Kim, et al.
European Journal of Medicinal Chemistry
|
March 6, 2021
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities
Huajian Zhu, Wenlong Li, Wen Shuai, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 27, 2013
Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2
Xiao-qin Zhao, Chun-ling Dai, Shinobu Ohnuma, et al.
Page
of 64
Search research articles
Search
Showing results (461-470 of 633) with videos related to
Sort By:
Page
of 64
Biochemical Pharmacology
|
February 12, 2020
Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor
Chao-Yun Cai, Wei Zhang, Jing-Quan Wang, et al.
Biochemical Pharmacology
|
June 14, 2021
CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)
Jing-Quan Wang, Bo Wang, Qiu-Xu Teng, et al.
Frontiers in Oncology
|
March 17, 2020
Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells
Jingqiu Wang, Jing-Quan Wang, Chao-Yun Cai, et al.
Plos One
|
October 21, 2009
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10)
Tong Shen, Ye-Hong Kuang, Charles R Ashby, et al.
Biochemical Pharmacology
|
May 13, 2019
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells
Zhuo-Xun Wu, Qiu-Xu Teng, Chao-Yun Cai, et al.
Oncology Reports
|
January 17, 2009
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
Zhi Shi, Smitaben Parmar, Xing-Xiang Peng, et al.
Pharmacological Research
|
January 30, 2017
Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib
Guan-Nan Zhang, Yun-Kai Zhang, Yi-Jun Wang, et al.
Cancer Science
|
July 21, 2007
Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells
Zhi Shi, Sandeep Jain, In-Wha Kim, et al.
European Journal of Medicinal Chemistry
|
March 6, 2021
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities
Huajian Zhu, Wenlong Li, Wen Shuai, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 27, 2013
Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2
Xiao-qin Zhao, Chun-ling Dai, Shinobu Ohnuma, et al.
Page
of 64